PRIME® Study on Real-World Disparities in LGBTQ+ Cancer Care Wins Prestigious William Campbell Felch Award
February 06 2024 - 6:00AM
Business Wire
The Alliance for Continuing Education in the Health Professions
has named PRIME® the winner of 2024 William Campbell Felch Award
for Outstanding Research in Continuing Education (CE) at its annual
meeting. This marks the third time PRIME has won the award in the
last five years.
The award-winning implementation science program focuses on
identifying and resolving underlying root causes of disparities in
care for cancer patients who identify as lesbian, gay, bisexual,
transgender, queer, or questioning, which aligns with the American
Society of Clinical Oncology’s recent call to action to address
suboptimal access to cancer prevention and high-quality cancer care
impacting sexual and gender minorities. Support for this
transformative project was provided to PRIME through grants from
Gilead Sciences, Bristol Myers Squibb, Merck Sharp & Dohme,
Pfizer, Lilly, Novartis, and Eisai.
With this program, PRIME sets a new standard for equity-focused
implementation science initiatives, offering a framework for
projects focused on improving the quality of healthcare for sexual
and gender non-conforming communities.
PRIME’s research-driven initiative was designed to identify and
address real-world disparities in LGBTQ+ cancer care and drive
sustainable change in practice across oncology care settings.
Measurable outcomes captured from two leading academic centers and
five community-based clinics revealed that while 65% of HCPs
(n=115) believe patients feel safe disclosing LGBTQ+ identity, only
24% of patients (n=817) reported feeling comfortable doing so.
Additionally, nearly 40% of patients reported increased confidence
in care if their healthcare provider shared pronouns or displayed
them on their badge. However, 0% of HCPs reported doing this. The
baseline data was built into audit-feedback sessions at each clinic
to facilitate action plans to advance equitable cancer care, which
included improving documentation with electronic medical records of
preferred pronouns, purchasing accessories to display to show
acceptance, and providing resources tailored to the needs of LGBTQ+
patients. Furthermore, healthcare providers significantly improved
commitment to discuss gender identity from very low baseline scores
of 12% increasing to 78% among academic HCPs and from only 1%
increasing to 68% among community HCPs. As evident from the
baseline data, these discussions were important to increasing
patients' feeling of confidence in care. These findings thereby
demonstrate the impact of building real-world patient insights into
the provider-facing interventions to motivate behavior change.
“The distinct healthcare needs of the LGBTQ+ community have been
underappreciated and overlooked for far too long. This landmark
initiative demonstrates how utilizing real-world patient insights
and research-driven education can be a sustainable catalyst for
advancing equitable cancer care. We are honored that this important
work has been recognized through the prestigious Felch award," says
Chris Napolitan, Managing Director of PRIME.
About PRIME
PRIME® is a leading research and medical education company that
advances the science of learning and behavior change among
providers, patients, payers, and health ecosystems to improve
competency, performance, and quality health outcomes. The scalable
and sustainable research and education that PRIME delivers has
measurably improved patient care for over 30 years. PRIME is part
of the Everyday Health Group.
About Everyday Health Group
The Everyday Health Group is a recognized leader in patient and
provider education, attracting an engaged audience of over 81
million health consumers and over 890,000 U.S. practicing
physicians and clinicians to its premier health and wellness
digital properties. Our mission is to drive better clinical and
health outcomes through decision-making informed by highly relevant
information, data and analytics. We empower healthcare providers
and consumers with trusted content and services delivered through
the Everyday Health Group's world-class brands. Everyday Health
Group is a division of Ziff Davis, Inc. (NASDAQ: ZD).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240206215279/en/
Chris Napolitan Managing Director PRIME
c.napolitan@primeinc.org
Ziff Davis (NASDAQ:ZD)
Historical Stock Chart
From Apr 2024 to May 2024
Ziff Davis (NASDAQ:ZD)
Historical Stock Chart
From May 2023 to May 2024